Antipsychotic-induced oxidative stress in rat brain

Neurotoxicity Research

Volumn 13, Issue 1, 2008, Pages 63-69

  Martins, Márcio R ^a   Petronilho, Fabrícia C ^a   Gomes, Karin M ^a   Dal Pizzol, Felipe ^a   Streck, Emilio L ^a   Quevedo, João ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Aripiprazole; Clozapine; Haloperidol; Olanzapine; Oxidative stress

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; BENZODIAZEPINE DERIVATIVE; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; HIPPOCAMPUS; MALE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT; WISTAR RAT; ANIMAL; BRAIN; DRUG EFFECT; METABOLISM;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRAIN; CLOZAPINE; CORPUS STRIATUM; HALOPERIDOL; HIPPOCAMPUS; MALE; OXIDATIVE STRESS; PIPERAZINES; PREFRONTAL CORTEX; QUINOLONES; RATS; RATS, WISTAR; SUPEROXIDES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 44649199519     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033368     Document Type: Article

References (48)

1. Abdul-Monim Z, GP Reynolds and JC Neill (2006) The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behav. Brain Res. 169, 263-273.
2. Angelucci F, L Aloe, SH Gruber, M Fiore and AA Mathe (2000) Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions. Int. J. Neuropsychopharmacol. 3, 13-25.
3. Arnaiz SL, MF Coronel and A Boveris (1999) Nitric oxide, superoxide and hydrogen peroxide production in brain mitochondria after haloperidol treatment. Nitric Oxide 3, 235-243.
4. Assis LC, G Scaini, PB Di-Pietro, AA Castro, CM Comim, EL Streck and J Quevedo (2007) Effect of antipsychotics on creatine kinase activity in rat brain. Basic Clin. Pharmacol. Toxicol. 101, 315-319. DOI:10.1111/j. 1742-7843.2007.00128.x.
5. Beuzen JN, N Taylor, K Wesnes and A Wood (1999) A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers. J. Psychopharmacol. 13, 152-158.
6. Bilder RM, RS Goldman, J Volavka, P Czobor, M Hoptman, B Sheitman, JP Lindenmayer, L Citrome, J McEvoy, M Kunz, M Chakos, TB Cooper, TL Horowitz and JA Lieberman (2002) Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am. J. Psychiatry 159, 1018-1028.
7. Buckley PF (2001) Broad therapeutic uses of atypical antipsychotic medications. Biol. Psychiatry 50, 912-924.
8. Cadet JL and JB Lohr (1989) Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E. Ann. NYAcad. Sci. 570, 176-185.
9. Carlson CD, PA Cavazzoni, PH Berg, H Wei, CM Beasley and JM Kane (2003) An integrated analysis of acute treatmentemergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: Comparisons with placebo, haloperidol, risperidone, or clozapine. J. Clin. Psychiatry 64, 898-906.
10. Dal-Pizzol F, F Kamt, MMR Vianna, N Schroder, J Quevedo, MS Benfato, JC Moreira and R Walz (2000) Lipid peroxida tion in hippocampus early and late after status epilepticus induced by pilocarpine or kainic acid in Wistar rats. Neurosci.Lett. 291, 179-182.
11. Dal-Pizzol F, F Klamt, MS Benfato, EA Bernard and JC Moreira (2001) Retinol supplementation induces oxidative stress and modulates antioxidant enzyme activities in rat Sertoli cells. Free Radic. Res. 34, 395-404.
12. De Grey AD (2005) Reactive oxygen species production in the mitochondrial matrix: Implications for the mechanism of mitochondrial mutation accumulation. Rejuvenation Res. 8, 13-17.
13. Desco M, JD Gispert, S Reig, J Sanz, J Pascau, F Sarramea, C Benito, A Santos, T Palomo and V Molina (2003) Cerebral metabolic patterns in chronic and recent-onset schizophrenia. Psychiatry Res. 122, 125-135.
14. Deutch AY, B Moghaddam, RB Innis, JH Krystal, GK Aghajanian, BS Bunney and DS Charney (1991) Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophrenia. Schizophr. Res. 4, 121-156.
15. Dixon LB, AF Lehman and J Levine (1995) Conventional antipsychotic medications for schizophrenia. Schizophr. Bull. 21, 567-577.
16. Draper HH and M Hadley (1990) Malondialdehyde determination as index of lipid peroxidation. Meth. Enzymol. 186, 421-431.
17. 2-receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 99, Suppl. S28-S31.
18. Gentile S (2007) Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder. J. Clin. Psychopharmacol. 27, 35-45.
19. Halliwell B (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
20. 1a receptor. Eur. J. Pharmacol. 441, 137-140.
21. Kapur S and G Remington (2001) Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia. Annu. Rev. Med. 52, 503-517.
22. Kern RS, MF Green, BA Cornblatt, JR Owen, RD McQuade, WH Carson, M Ali and R Marcus (2006) The neurocognitive effects of aripiprazole: An open-label comparison with olanzapine. Psychopharmacology (Berl.) 187, 312-320.
23. Levine RL, D Garland and CN Oliver (1990) Determination of carbonyl content in oxidatively modified proteins. Meth. Enzymol. 186, 464-478.
24. Lohr JB, JL Cadet, MA Lohr, L Larson, E Wasli, L Wade, R Hylton, C Vidoni, DV Jeste and RJ Wyatt (1988) Vitamin E in the treatment of tardive dyskinesia: The possible involvement of free radical mechanisms. Schizophr. Bull. 14, 291-296.
25. Lohr JB, R Kuczenski, HS Bracha, M Moir and DV Jeste (1990) Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol. Psychiatry 28, 535-539.
26. Lowry OH, NJ Rosebrough, AL Farr and RJ Randall (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-267.
27. Mahadik SP, H Laev, A Korenovsky and SE Karpiak (1988) Haloperidol alters rat CNS cholinergic system: Enzymatic and morphological analyses. Biol. Psychiatry 24, 199-217.
28. Mahadik SP and S Mukherjee (1996) Free radical pathology and antioxidant defense in schizophrenia: A review. Schizophr. Res. 19, 1-17.
29. Mahadik SP, S Mukherjee, R Scheffer, EE Correnti and JS Mahadik (1996) Elevated plasma lipid peroxides at the onset of non-affective psychosis. Biol. Psychiatry 43, 674-679.
30. Marchbanks RM, M Ryan and IN Day (2003) A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr. Res. 65, 33-38.
31. McQuade RD, KD Burris, S Jordan, et al. (2002) Aripiprazole: A dopamine-serotonin system stabilizer. Int. J. Neuropsychopharmacol. 5, S176. (Abstr.)
32. Munakata K, K Iwamoto and M Bundo (2005) Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 57, 525-532.
33. Parikh V, MM Khan and SP Mahadik (2003) Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J. Psychiatr. Res. 37, 43-51.
34. Parikh V, AV Terry and MM Khan (2004) Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine. Psychopharmacology (Berl.) 172, 365-374.
35. Peet M, J Laugharne and N Rangarajan (1993) Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment. Int. Clin. Psychopharmacol. 8, 151-153.
36. Poderoso JJ, MC Carreras and C Lisdero (1996) Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 328, 85-92.
37. Polydoro M, N Schröder and MN Lima, F Caldana, DC Laranja, E Bromberg, R Roesler, J Quevedo, JC Moreira and F Dal-Pizzol (2004) Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol. Biochem. Behav. 78, 751-756.
38. Reddy R and JK Yao (1996) Free radical pathology in schizophrenia: A review. Prostaglandins Leukot. Essent. Fatty Acids 55, 33-43.
39. Reinke A, MR Martins, MS Lima, JC Moreira, F Dal-Pizzol and J Quevedo (2004) Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain. Neurosci. Lett. 372, 157-160.
40. Rosengarten H and D Quartermain (2002) The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteenmonth-old rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 1047-1054.
41. Seeman P, T Lee, M Chau-Wong and K Wong (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261, 717-719.
42. Sharma T and D Mockler (1998) The cognitive efficacy of atypical antipsychotics in schizophrenia. J. Clin. Psychopharmacol. 18, 12-19.
43. Streck EL, GT Rezin, LM Barbosa, LC Assis, E Grandi and J Quevedo (2007) Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 376 (1-2), 127-133. DOI:10.1007/s00210-007-0178-2
44. Terry AV, WD Hill, V Parikh, DR Evans, JL Waller and SP Mahadik (2002) Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats. Psychopharmacology 164, 360-368.
45. Terry AV, WD Hill, V Parikh, JL Waller, DR Evans and SP Mahadik (2003) Differential effects of haloperidol, risperidone and clozapine exposure on cholinergic markers and spatial learning performance in rats. Neuropsychopharmacology 28, 300-309.
46. Terry AV and SP Mahadik (2007) Time-dependent cognitive deficits associated with first and second generation antipsychotics: Cholinergic dysregulation as a potential mechanism. J. Pharmacol. Exp. Ther. 320, 961-968.
47. Tollefson GD, CM Beasley Jr, RN Tamura, PV Tran and JH Potvin (1997) Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am. J. Psychiatry 154, 1248-1254.
48. Velligan DI, J Newcomer, J Pultz, J Csernansky, AL Hoff, R Mahurin and AL Miller (2002) Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr. Res. 53, 239-248.